Related Experiment Video

Updated: May 28, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk

Matthew H Law, Grant W Montgomery, Kevin M Brown

    The Journal of Investigative Dermatology
    |October 14, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Related Experiment Videos

    Last Updated: May 28, 2026

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
    07:47

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

    Published on: September 15, 2023

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Related Concept Videos

    Non-LTR Retrotransposons03:18

    Non-LTR Retrotransposons

    As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

    Articles linked to this work by shared authors, journal, and citation graph.

    Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.

    medRxiv : the preprint server for health sciences·2026

    Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2025

    Federated Deep Learning Enables Cancer Subtyping by Proteomics.

    Cancer discovery·2025

    Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma.

    JAMA dermatology·2025

    DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

    JCO precision oncology·2024

    Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.

    PloS one·2023

    TLR4 epidermal genetic deletion protects against acute and tumorigenic UV exposure in SKH-1 mouse skin.

    The Journal of investigative dermatology·2026

    Evidence that IL-4/IL-13-Responsive IGFLs Promote Allergic Skin Inflammation.

    The Journal of investigative dermatology·2026

    DNPH1 exerts context-dependent tumor-promoting and -repressing functions during melanoma development.

    The Journal of investigative dermatology·2026

    Skin Cancer Risk Stratification and Outcomes in Swedish Solid Organ Transplant Recipients.

    The Journal of investigative dermatology·2026

    Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas.

    The Journal of investigative dermatology·2026

    The AhR-TFAP2A Axis Regulates Melanosome Transport by Directly Targeting Myosin Va and Mlph.

    The Journal of investigative dermatology·2026

    Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01).

    Cancer research communications·2026

    TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR.

    Endocrine-related cancer·2026

    Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors.

    Endocrine-related cancer·2026

    Trends in Location of Death for Individuals with Primary Ocular Cancer in the United States.

    Ophthalmic epidemiology·2026

    Prognostic Value of Intraoperative Desmopressin Test for Long-Term Remission in Cushing's Disease: A Prospective Cohort Study.

    Neurosurgery·2026

    Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma.

    Cancer investigation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us